Skip to content
Citation only via OpenAlex

The Role of Plasminogen Activator Inhibitor Type-1 in Fibrosis

Panagiotis Flevaris, Douglas E. Vaughan

Seminars in Thrombosis and Hemostasis · 2016 · ▲ 160 citations

Abstract

Extracellular matrix (ECM) deposition during wound healing is a physiological response to an insult. Wound healing becomes deregulated in the setting of chronic injury or long-standing metabolic disease, leading to the accumulation of ECM components and fibrosis. Matrix protein turnover is determined by the rate of synthesis as well as the rate of proteolytic degradation and clearance by matrix metalloproteinases (MMPs). The persistent activation of interstitial myofibroblasts, coupled with defects in matrix proteolysis, ultimately disrupts tissue architecture and leads to biochemical and mechanical organ dysfunction with eventual organ failure. Plasminogen activator inhibitor type-1 (PAI-1) regulates tissue homeostasis and wound healing by inhibiting plasmin-mediated MMP activation. Multiple reports using models of liver, lung, and kidney fibrosis suggest that PAI-1 deficiency or inhibition of PAI-1 activity attenuates fibrosis. The disinhibition of plasmin-mediated MMP activation leads to collagen degradation and its diminished accumulation, resulting in the reduction of fibrotic matrix deposition in these organs. Paradoxically, homozygous deficiency of PAI-1 promotes age-dependent spontaneous cardiac fibrosis, suggesting a protective role for PAI-1 in the heart. It remains unclear whether PAI-1-deficient cardiac fibroblasts have increased proliferative, migratory, or differentiation capabilities, that allow them to overcome increased plasmin and MMP activity and matrix clearance. In this review, we examine the specific roles of PAI-1 in fibrosis of different organs including the lung, liver, kidney, and cardiovascular system.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.1055/s-0036-1586228
Canonical
link ↗
Fetched
2026-10-25 MST

Cite this

APA
Flevaris, P., &amp; Vaughan, D.E. (2016). The Role of Plasminogen Activator Inhibitor Type-1 in Fibrosis. <em>Seminars in Thrombosis and Hemostasis</em>. https://doi.org/10.1055/s-0036-1586228
Vancouver
Flevaris P, Vaughan DE. The Role of Plasminogen Activator Inhibitor Type-1 in Fibrosis. Seminars in Thrombosis and Hemostasis. 2016. doi:10.1055/s-0036-1586228.
BibTeX
@article{panagiotis2016TheRol, title = {The Role of Plasminogen Activator Inhibitor Type-1 in Fibrosis}, author = {Panagiotis Flevaris and Douglas E. Vaughan}, journal = {Seminars in Thrombosis and Hemostasis}, year = {2016}, doi = {10.1055/s-0036-1586228}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings